Stocks rise in Tokyo, Hong Kong, Shanghai amid hopes that vaccine will spur global rebound
BEIJING — Asian stocks rose Tuesday after Chinese manufacturing improved, with investors looking ahead to U.S. Federal Reserve Chairman Jerome Powell’s appearance before legislators.
Benchmarks in Shanghai, Tokyo, Hong Kong and Sydney advanced.
Wall Street’s benchmark S&P 500 index closed down 0.5% overnight but ended November up 10.8% for its biggest monthly gain since April.
Investors are increasingly optimistic about the expected development of a coronavirus vaccine despite caution about the short-term economic impact of rising virus cases in the United States and Europe.
The future “seems incredibly bright and bullish,” Stephen Innes of Axi said in a report.
The Shanghai Composite Index SHCOMP, +1.77% gained 1.3% while the Nikkei 225 NIK, +1.33% in Tokyo advanced 1.4%. The Hang Seng HSI, +0.85% in Hong Kong added 0.9%.
The Kospi 180721, +1.65% in Seoul advanced 1.6% and the S&P/ASX 200 XJO, +1.08% in Sydney was 1% higher. New Zealand NZ50GR, -0.30% declined while markets in Taiwan Y9999, +1.18%, Singapore STI, +0.29% and Indonesia JAKIDX, +2.00% gained.
An index of Chinese manufacturing released by a business magazine, Caixin, hit a decade high in November as the country’s recovery from the pandemic gained strength. A separate survey Monday by the government statistics agency showed activity at a three-year high.
Strength in the Chinese economy is helping offset unease about rising virus cases in the United States and Europe and possible renewed controls on business and travel.
In Washington, Powell said in a statement Monday that economic prospects are “extraordinarily uncertain” after the pace of improvement moderated. He said a full recovery is unlikely until the public is confident the disease is under control.
Powell was due to appear Tuesday before the Senate Banking Committee with Treasury Secretary Steven Mnuchin. The panel oversees the $2 trillion aid package approved by Congress in March.
The S&P 500 SPX, -0.46% declined to 3,621.63. The Dow Jones Industrial Average DJIA, -0.90% lost 0.9% to 29,638.64. The Nasdaq composite COMP, -0.05% slipped 0.1% to 12,198.74.
The slide followed reports showing the pandemic dragging down U.S. economic activity in the near future. But investors appear to be looking beyond that.
Investors are encouraged by the end of uncertainty about the outcome of the U.S. presidential election. They are reassured Washington will be under divided control, reducing the chances of big changes in taxes or regulation.
Markets also have been heartened by announcements from pharmaceutical companies of advances in vaccine development.
One developer, Moderna MRNA, +20.23%, said Monday it is ready to apply for emergency approval in the United States and Britain. Pfizer PFE, +2.90% and German partner BioNTech BNTX, +12.95% are asking to begin vaccinations in the U.S. in December. British regulators also are assessing the Pfizer shot and another from AstraZeneca AZN, +0.62%.
In energy markets, benchmark U.S. crude oil CLF21, -0.22% lost 36 cents to $44.98 per barrel in electronic trading on the New York Mercantile Exchange. The contract fell 19 cents to $45.34 on Monday. Brent crude BRNF21, used to price international oils, sank 32 cents to $47.56 per barrel in London. It dropped 59 cents from the previous session to $47.59.
The dollar USDJPY, 0.07% rose to 104.43 yen from Monday’s 104.34 yen.